A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Clinical trial NCT06944522 · RECRUITING

Trial details

NCT number: NCT06944522
Sponsor: BlueRock Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinsons Disease (PD)

Start date: 2025-06-17
Primary completion: 2027-03-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.